Canadian Cannabis Market: Page 2

Tilray Expands Cannabis Cultivation Capacity in Canada, Europe to Meet International Demand

The company expanded cultivation in Quebec and Portugal, increasing its total annual production capacity to approximately 275 metric tonnes.

Aurora Cannabis Urges Shareholders to Take No Action on Curaleaf’s Unsolicited Takeover Bid

The company claims Curaleaf’s hostile takeover bid is designed to pressure Aurora’s shareholders into a short-term decision for the benefit of Curaleaf shareholders.

Curaleaf Launches Takeover Bid to Acquire Aurora Cannabis, Invites Aurora Shareholders to Tender Bid

The company filed the formal offer and takeover bid circular, which will be delivered to Aurora shareholders.

Tilray Medical Accelerates Commercial Expansion in UK With Direct-to-Patient Launch

The launch, through Lyphe Clinic and Lyphe Dispensary, expands direct patient access to the company’s cannabis medicines across the U.K.

Canopy Growth Secures Renewed EU GMP Certification at Kincardine Cultivation Facility

The renewed certification maintains Kincardine’s role in Canopy Growth’s EU GMP flower supply chain as the European medical cannabis business grows.

Curaleaf Intends to Launch Takeover Bid for Aurora Cannabis

Curaleaf is taking its proposal directly to Aurora shareholders after repeated attempts to engage privately failed to gain substantive discussions.

High Tide Closes $40M Senior Secured Credit Facilities

The new facilities materially increase financial flexibility and lower the company's cost of capital.

SNDL Passes EU-GMP Audit at Atholville Facility in New Brunswick

The milestone validates operational excellence and strengthens international medical cannabis opportunities.

SNDL Acquires Assets From Parallel, Positions for Nasdaq-Consolidated Operations

The acquisition includes 56 dispensaries and three cultivation and manufacturing facilities in Florida, Massachusetts and Texas.

Aurora Cannabis Subsidiary Safari Flower Co. Receives EU-GMP Certification at Niagara Facility

The achievement strengthens Safari's ability to serve international medical cannabis markets under the strictest regulations.

Avicanna Introduces QUIX Rapid-Onset Medical Cannabis Portfolio

The initial medical cannabis SKUs, including rapid-onset capsules and soft chews, are planned for Q3 2026, improving patient access to accurately dosed products.

Aurora Named to TIME Canada’s Best Companies 2026 List

The company is the first and only cannabis company to receive the recognition.

Previous Page

Page 2 of 20

Next Page